We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Safety and Efficacy of SH-1028 in Locally Advanced or Metastatic NSCLC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03823807
Recruitment Status : Unknown
Verified January 2019 by Nanjing Sanhome Pharmaceutical, Co., Ltd..
Recruitment status was:  Not yet recruiting
First Posted : January 30, 2019
Last Update Posted : February 1, 2019
Sponsor:
Information provided by (Responsible Party):
Nanjing Sanhome Pharmaceutical, Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : March 2021